HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

FENC

Fennec Pharmaceuticals Inc

Last Close
Dec 11 • 04:00PM ET
6.14
Dollar change
0.00
Percentage change
0.00 		%
Healthcare • Biotechnology • USA • NASD
Peers: VRTX BMRN ALNY SRPT AGEN XOMA ACAD NBIX PRQR IONS
 | Held by: IWM VTI IWN VTWO IWC IWO RSSL VTWV UWM VTWG
Scroll to Statements
IndexRUT P/E- EPS (ttm)-0.10 Insider Own16.48% Shs Outstand27.42M Perf Week1.15%
Market Cap168.42M Forward P/E31.49 EPS next Y0.20 Insider Trans-0.52% Shs Float22.91M Perf Month44.13%
Income-1.13M PEG- EPS next Q-0.12 Inst Own54.82% Short Float9.18% Perf Quarter13.91%
Sales49.35M P/S3.41 EPS this Y90.00% Inst Trans12.58% Short Ratio17.27 Perf Half Y-10.63%
Book/sh-0.19 P/B- EPS next Y425.00% ROA-2.91% Short Interest2.10M Perf Year-33.91%
Cash/sh1.47 P/C4.18 EPS next 5Y- ROE- 52W Range3.96 - 11.92 Perf YTD-45.28%
Dividend Est.- P/FCF7.11 EPS past 5Y-2.95% ROI-4.61% 52W High-48.49% Beta0.35
Dividend TTM- Quick Ratio7.64 Sales past 5Y236.90% Gross Margin93.52% 52W Low55.05% ATR (14)0.41
Dividend Ex-Date- Current Ratio7.80 EPS Y/Y TTM94.99% Oper. Margin3.41% RSI (14)64.48 Volatility6.41% 8.74%
Employees29 Debt/Eq- Sales Y/Y TTM278.09% Profit Margin-2.30% Recom1.00 Target Price13.75
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-198.43% Payout- Rel Volume0.40 Prev Close6.14
Sales Surprise-22.38% EPS Surprise-133.33% Sales Q/Q7.05% EarningsNov 07 BMO Avg Volume121.78K Price6.14
SMA2013.28% SMA5025.90% SMA200-10.19% Trades Volume48,463 Change0.00%
Date Action Analyst Rating Change Price Target Change
Nov-22-22Upgrade Cantor Fitzgerald Neutral → Overweight $9 → $12
Sep-07-22Initiated CapitalOne Overweight $11
Aug-08-22Resumed Craig Hallum Buy $14
Jun-05-20Initiated Cantor Fitzgerald Overweight $18
Oct-11-18Initiated Goldman Buy
Nov-13-24 06:27AM
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
(GlobeNewswire) +5.91%
Nov-09-24 02:00AM
Fennec Pharmaceuticals Inc (FENC) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...
(GuruFocus.com)
Nov-07-24 06:13AM
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
(GlobeNewswire) -11.92%
Oct-31-24 06:23AM
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
(GlobeNewswire)
Oct-28-24 06:23AM
Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company's Next Stage of Growth
(GlobeNewswire) +11.56%
06:56AM Loading…
Sep-05-24 06:56AM
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Aug-14-24 01:57AM
Q2 2024 Fennec Pharmaceuticals Inc Earnings Call
(Thomson Reuters StreetEvents) -8.89%
Aug-13-24 06:05AM
Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
(GlobeNewswire) -6.40%
Aug-06-24 04:31PM
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024
(GlobeNewswire)
Aug-05-24 06:26AM
Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director
(GlobeNewswire)
Jul-29-24 06:15AM
3 Dirt-Cheap Stocks Under $10 That Could EXPLODE!
(InvestorPlace)
Jul-15-24 08:32AM
Implied Volatility Surging for Fennec (FENC) Stock Options
(Zacks)
Jul-01-24 06:00AM
Fennec Pharmaceuticals Announces Management Change
(GlobeNewswire)
Jun-25-24 04:35PM
Fennec Announces Results of Annual Meeting
(GlobeNewswire)
May-15-24 08:44AM
HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating
(MT Newswires)
10:53AM Loading…
May-14-24 10:53AM
FENC Stock Earnings: Fennec Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
(InvestorPlace) -26.75%
07:20AM
Fennec Pharmaceuticals Swings to Q1 Profit on Higher Sales, Licensing Revenue
(MT Newswires)
06:03AM
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
(GlobeNewswire)
May-07-24 06:15PM
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
(GlobeNewswire)
Apr-23-24 08:01AM
Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing
(MT Newswires)
Apr-05-24 07:00PM
Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)
(GuruFocus.com)
Mar-27-24 07:00PM
Chief Financial Officer Robert Andrade Sells 13,975 Shares of Fennec Pharmaceuticals Inc (FENC)
(GuruFocus.com)
Mar-26-24 01:00AM
Chief Financial Officer Robert Andrade Sells Shares of Fennec Pharmaceuticals Inc (FENC)
(GuruFocus.com)
Mar-22-24 09:49AM
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript
(Insider Monkey)
05:04AM
Q4 2023 Fennec Pharmaceuticals Inc Earnings Call
(Thomson Reuters StreetEvents)
Mar-21-24 02:52PM
FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
(InvestorPlace)
06:00AM
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
(GlobeNewswire)
Mar-19-24 10:14AM
Fennec (FENC) Signs Licensing Deal With Norgine, Stock Up
(Zacks)
06:01AM
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
(GlobeNewswire)
Mar-17-24 09:00PM
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
(GlobeNewswire)
07:04AM Loading…
Feb-29-24 07:04AM
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
(GlobeNewswire)
Feb-01-24 05:55AM
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
(GlobeNewswire)
Jan-06-24 03:01AM
Insider Sell: CFO Robert Andrade Sells 30,000 Shares of Fennec Pharmaceuticals Inc
(GuruFocus.com)
Dec-05-23 05:55AM
Fennec Announces Incremental $5 Million Investment from Petrichor
(GlobeNewswire)
Nov-09-23 04:50PM
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Nov-07-23 09:40AM
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call Transcript
(Insider Monkey)
02:10AM
Q3 2023 Fennec Pharmaceuticals Inc Earnings Call
(Thomson Reuters StreetEvents)
Nov-06-23 05:59AM
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update
(GlobeNewswire) +15.36%
Oct-30-23 06:45AM
Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023
(GlobeNewswire)
Sep-07-23 05:59AM
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Aug-10-23 12:53PM
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Call Transcript
(Insider Monkey)
Aug-03-23 05:59AM
Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update
(GlobeNewswire) -7.29%
Jul-31-23 05:30AM
Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023
(GlobeNewswire) +8.66%
Jun-12-23 05:00PM
Fennec Announces Results of Annual Meeting
(GlobeNewswire)
Jun-08-23 02:53PM
Retail investors who hold 38% of Fennec Pharmaceuticals Inc. (NASDAQ:FENC) gained 13%, institutions profited as well
(Simply Wall St.)
Jun-06-23 05:44AM
Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients
(GlobeNewswire)
May-11-23 06:01AM
Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
(GlobeNewswire)
May-08-23 06:15AM
Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023
(GlobeNewswire)
Apr-28-23 09:26AM
When Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Become Profitable?
(Simply Wall St.)
Apr-01-23 08:12AM
Investors in Fennec Pharmaceuticals (NASDAQ:FENC) have made a notable return of 52% over the past three years
(Simply Wall St.)
Mar-31-23 08:03AM
Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients
(GlobeNewswire)
Mar-30-23 05:55AM
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results
(GlobeNewswire)
Mar-24-23 06:30AM
7 Biotech Stocks Sitting in the Sweet Spot
(InvestorPlace)
Feb-23-23 08:44AM
Why Earnings Season Could Be Great for Adherex Technologies (FENC)
(Zacks)
Jan-31-23 06:00AM
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA
(GlobeNewswire) +6.26%
Jan-25-23 07:19AM
Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK® (sodium thiosulfate injection) to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric Patients
(GlobeNewswire) +8.27%
Jan-23-23 11:57AM
RTP drugmaker Fennec sues Cipla over generics effort
(American City Business Journals)
Dec-17-22 09:55AM
Institutions own 28% of Fennec Pharmaceuticals Inc. (NASDAQ:FENC) shares but individual investors control 55% of the company
(Simply Wall St.)
Nov-11-22 07:10AM
Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update
(GlobeNewswire)
Nov-01-22 10:28AM
Fennec Pharmaceuticals Inc. (NASDAQ:FENC): Are Analysts Optimistic?
(Simply Wall St.)
Oct-17-22 08:00AM
Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United States
(GlobeNewswire)
Sep-26-22 07:35AM
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from Petrichor
(GlobeNewswire) -8.30%
Sep-21-22 02:19PM
RTP pharma to see $20M infusion on heels of drug winning approval
(American City Business Journals) +11.93%
01:05PM
After Two FDA Rejections, Fennec Pharma Lead Drug Scores US Approval For Chemo-Induced Hearing Loss
(Benzinga)
07:00AM
Fennec Pharmaceuticals Announces FDA Approval of PEDMARK® (Sodium Thiosulfate Injection)
(GlobeNewswire)
06:05AM
U.S. FDA approves Fennec's hearing loss therapy
(Reuters)
Aug-22-22 07:04AM
Fennec Pharmaceuticals Closes First $5 Million Investment From Petrichor
(GlobeNewswire)
Aug-12-22 06:59AM
Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business Update
(GlobeNewswire)
Aug-01-22 02:59PM
RTP drugmaker secures up to $45M despite regulatory speed bumps
(American City Business Journals)
07:30AM
Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor
(GlobeNewswire)
Jul-10-22 08:42AM
What Kind Of Shareholders Own Fennec Pharmaceuticals Inc. (NASDAQ:FENC)?
(Simply Wall St.)
Jun-14-22 06:00PM
Fennec Announces Results of Annual Meeting
(GlobeNewswire)
May-23-22 07:29AM
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
(GlobeNewswire)
May-12-22 06:00AM
Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update
(GlobeNewswire)
May-06-22 05:17PM
Inflation crushes market caps of Triangle's biggest public companies except these ones
(American City Business Journals)
May-03-22 09:55AM
Can Adherex Technologies Inc. (FENC) Climb 92% to Reach the Level Wall Street Analysts Expect?
(Zacks)
Apr-27-22 06:00AM
Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resubmission for PEDMARK
(GlobeNewswire) -9.27%
Mar-25-22 07:00AM
Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference
(GlobeNewswire)
Mar-24-22 06:00AM
Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for Pedmark
(GlobeNewswire) -6.41%
Feb-28-22 06:00AM
Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Business Update
(GlobeNewswire)
Jan-31-22 06:00AM
Fennec Pharmaceuticals Announces Management Change
(GlobeNewswire) +5.20%
Jan-27-22 05:38PM
Hartford Financial Management Inc. Buys Exelon Corp, American Electric Power Co Inc, Pinnacle ...
(GuruFocus.com) -7.54%
Dec-14-21 07:50PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC
(ACCESSWIRE)
Dec-13-21 10:08AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC
(PR Newswire)
Dec-01-21 07:06AM
RTP drugmaker suffers another regulatory setback
(American City Business Journals) -11.39%
Nov-30-21 04:20PM
Fennec (FENC) Gets CRL From FDA for Pedmark, Stock Down
(Zacks) -8.16%
10:57AM
FENC Fennec Pharmaceuticals Inc. Investors Who Have Lost More Than $25,000 Are Encouraged To Contact Kehoe Law Firm, P.C. Securities Class Action Investigation
(GlobeNewswire)
06:00AM
Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
(GlobeNewswire)
05:49AM
When Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Breakeven?
(Simply Wall St.)
Nov-29-21 07:23PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC
(GlobeNewswire) -50.41%
07:24AM
Fennec Pharmaceuticals Expects FDA Rejection for New Drug
(Investing.com)
06:00AM
Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
(GlobeNewswire)
Nov-10-21 06:00AM
Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update
(GlobeNewswire)
Oct-05-21 08:30AM
4 Breakout Stocks for Impressive Returns
(Zacks)
Sep-29-21 02:27PM
Hedge Funds Are Piling Into Fennec Pharmaceuticals Inc. (FENC)
(Insider Monkey)
Sep-09-21 06:00AM
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Aug-10-21 06:00AM
Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Business Update
(GlobeNewswire)
Aug-02-21 03:18AM
Is Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Popular Amongst Institutions?
(Simply Wall St.)
Jun-29-21 05:30PM
Fennec Announces Results of Annual Meeting
(GlobeNewswire)
Jun-24-21 06:00AM
Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
(GlobeNewswire) +7.52%
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Raykov RostyDirectorDec 05 '24Sale6.047964,80866,432Dec 05 04:24 PM
ROSTISLAV RAYKOVDirectorDec 05 '24Proposed Sale6.047964,808Dec 05 04:00 PM
Raykov RostyDirectorDec 03 '24Sale6.131,63510,02367,228Dec 04 05:20 PM
ROSTISLAV RAYKOVDirectorDec 03 '24Proposed Sale6.131,63510,023Dec 03 04:03 PM
RALLIS CHRIS ADirectorDec 02 '24Option Exercise2.6910,00026,90058,623Dec 02 07:07 PM
RALLIS CHRIS ADirectorDec 02 '24Sale6.146,40939,35152,214Dec 02 07:07 PM
CHRIS A RALLISDirectorDec 02 '24Proposed Sale6.146,40939,344Dec 02 04:06 PM
Andrade RobertCHIEF FINANCIAL OFFICERNov 18 '24Option Exercise2.4515,81638,749127,381Nov 18 05:02 PM
Raykov RostyDirectorNov 04 '24Sale4.312,43110,47866,432Nov 04 05:30 PM
ROSTISLAV RAYKOVDirectorNov 04 '24Proposed Sale4.312,43110,478Nov 04 04:02 PM
RALLIS CHRIS ADirectorOct 08 '24Option Exercise2.551,9604,99850,029Oct 10 05:14 PM
RALLIS CHRIS ADirectorOct 08 '24Sale4.531,4066,36948,623Oct 10 05:14 PM
Raykov RostyDirectorOct 01 '24Sale4.942,43112,00966,432Oct 01 05:11 PM
ROSTISLAV RAYKOVDirectorOct 01 '24Proposed Sale4.942,43112,009Oct 01 04:07 PM
Haigh AdrianDirectorSep 05 '24Proposed Sale5.0020,246101,230Sep 05 05:02 PM
Raykov RostyDirectorSep 04 '24Sale5.522,43113,41966,432Sep 04 06:48 PM
ROSTISLAV RAYKOVDirectorSep 04 '24Proposed Sale5.522,43113,419Sep 04 04:05 PM
ROSTISLAV RAYKOVOfficerAug 01 '24Proposed Sale6.262,43115,206Aug 01 04:21 PM
Raykov RostyCHIEF EXECUTIVE OFFICERAug 01 '24Sale6.252,43115,206187,471Aug 01 04:08 PM
RALLIS CHRIS ADirectorJul 05 '24Option Exercise2.791,7925,00047,630Jul 08 04:05 PM
RALLIS CHRIS ADirectorJul 05 '24Sale6.031,1737,07346,457Jul 08 04:05 PM
Raykov RostyCHIEF EXECUTIVE OFFICERJul 02 '24Sale6.132,43114,902187,471Jul 02 05:55 PM
Raykov RostyCHIEF EXECUTIVE OFFICERJun 03 '24Sale6.762,43116,434187,471Jun 03 05:12 PM
Raykov RostyCHIEF EXECUTIVE OFFICERMay 01 '24Sale9.112,43122,152187,471May 02 04:59 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 22 '24Option Exercise2.3122,22351,33522,223Apr 22 07:34 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 19 '24Option Exercise2.3122,22251,33322,222Apr 22 07:34 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 19 '24Sale9.3422,222207,4420Apr 22 07:34 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 22 '24Sale9.3222,223207,0290Apr 22 07:34 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 17 '24Sale9.9122,222220,22022,222Apr 18 09:43 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 18 '24Sale9.6222,222213,7760Apr 18 09:43 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 15 '24Sale10.3022,222228,79322,222Apr 16 06:00 PM
Haigh AdrianCHIEF OPERATING OFFICERApr 16 '24Sale10.2822,222228,3890Apr 16 06:00 PM
RALLIS CHRIS ADirectorApr 15 '24Option Exercise10.451,38914,51545,838Apr 15 06:15 PM
RALLIS CHRIS ADirectorApr 15 '24Sale10.458008,36044,449Apr 15 06:15 PM
Raykov RostyCHIEF EXECUTIVE OFFICERApr 04 '24Sale10.8944,283482,400231,771Apr 05 04:56 PM
Raykov RostyCHIEF EXECUTIVE OFFICERApr 05 '24Sale10.7544,300476,269187,471Apr 05 04:56 PM
Raykov RostyCHIEF EXECUTIVE OFFICERApr 03 '24Sale10.7840,584437,451276,054Apr 03 05:37 PM
RALLIS CHRIS ADirectorMar 26 '24Option Exercise2.314,32910,00045,249Mar 27 04:24 PM
RALLIS CHRIS ADirectorMar 26 '24Sale10.972,11423,19140,920Mar 27 04:24 PM
Andrade RobertCHIEF FINANCIAL OFFICERMar 26 '24Sale10.9013,975152,34691,771Mar 27 04:22 PM
Andrade RobertCHIEF FINANCIAL OFFICERMar 25 '24Sale11.0013,975153,690105,746Mar 25 07:31 PM
Andrade RobertCHIEF FINANCIAL OFFICERJan 04 '24Sale10.6415,000159,600134,721Jan 05 05:24 PM
Andrade RobertCHIEF FINANCIAL OFFICERJan 05 '24Sale10.4115,000156,150119,721Jan 05 05:24 PM
Raykov RostyCHIEF EXECUTIVE OFFICERDec 28 '23Option Exercise1.598,54013,579291,127Dec 29 04:30 PM
Raykov RostyCHIEF EXECUTIVE OFFICERDec 28 '23Sale11.553,65642,227287,471Dec 29 04:30 PM
RALLIS CHRIS ADirectorDec 26 '23Option Exercise1.593,1444,99946,178Dec 28 04:02 PM
RALLIS CHRIS ADirectorDec 26 '23Sale10.901,39015,15144,788Dec 28 04:02 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.